Bain Capital Life Sciences Investors, LLC Long-Term Concentrated

CIK: 0001703031 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value ($000): $1,029,621 (100.0% shares, 0.0% debt)

Holdings (34)

— SPRINGWORKS THERAPEUTICS INC 26.5%

Value ($000) $272,679 Shares 4,831,307 Est. Cost $21.68 Unrealized —

— DYNAVAX TECHNOLOGIES CORP 8.9%

Value ($000) $91,219 Shares 8,415,000 Est. Cost $9.83 Unrealized —

ARQT ARCUTIS BIOTHERAPEUTICS INC 7.4%

Value ($000) $76,641 Shares 3,979,292 Est. Cost $26.87 Unrealized -37.0%

PHVS PHARVARIS N V 5.6%

Value ($000) $57,680 Shares 3,180,601 Est. Cost $31.46 Unrealized -44.1%

RPID RAPID MICRO BIOSYSTEMS INC 5.6%

Value ($000) $57,271 Shares 8,434,560 Est. Cost $20.66 Unrealized -64.4%

NUVL NUVALENT INC 4.6%

Value ($000) $47,615 Shares 3,428,014 Est. Cost $29.01 Unrealized -49.9%

CRNX CRINETICS PHARMACEUTICALS IN 4.3%

Value ($000) $44,552 Shares 2,029,701 Est. Cost $18.52 Unrealized +9.3%

— EQRX INC 4.0%

Value ($000) $41,315 Shares 10,003,573 Est. Cost $6.82 Unrealized —

CCCC C4 THERAPEUTICS INC 3.9%

Value ($000) $39,840 Shares 1,642,210 Est. Cost $29.00 Unrealized -16.3%

AMLX AMYLYX PHARMACEUTICALS INC 3.4%

Value ($000) $35,415 Shares 2,756,050 Est. Cost $22.45 Unrealized 0.0%

— MERSANA THERAPEUTICS INC 2.5%

Value ($000) $26,023 Shares 6,522,030 Est. Cost $15.29 Unrealized —

— 2SEVENTY BIO INC 2.3%

Value ($000) $24,036 Shares 1,408,901 Est. Cost $18.15 Unrealized —

— APTINYX INC 2.0%

Value ($000) $20,184 Shares 8,891,758 Est. Cost $8.16 Unrealized —

XLO XILIO THERAPEUTICS INC 1.9%

Value ($000) $19,834 Shares 2,805,413 Est. Cost $17.03 Unrealized -33.7%

NRIX NURIX THERAPEUTICS INC 1.7%

Value ($000) $17,993 Shares 1,284,313 Est. Cost $25.20 Unrealized -29.6%

AVIR ATEA PHARMACEUTICALS INC 1.7%

Value ($000) $17,946 Shares 2,485,638 Est. Cost $32.23 Unrealized -78.9%

SVRA SAVARA INC 1.5%

Value ($000) $15,226 Shares 11,622,598 Est. Cost $1.49 Unrealized -19.0%

TNGX TANGO THERAPEUTICS INC 1.4%

Value ($000) $14,567 Shares 1,921,790 Est. Cost $11.99 Unrealized -27.7%

— MARINUS PHARMACEUTICALS INC 1.3%

Value ($000) $13,380 Shares 1,431,058 Est. Cost $15.48 Unrealized —

— RESEARCH ALLIANCE CORP II 0.9%

Value ($000) $9,760 Shares 1,000,000 Est. Cost $10.25 Unrealized —

— SOLID BIOSCIENCES INC 0.9%

Value ($000) $9,516 Shares 7,929,918 Est. Cost $7.99 Unrealized —

ANNX ANNEXON INC 0.9%

Value ($000) $8,850 Shares 3,241,628 Est. Cost $23.46 Unrealized -73.8%

IVVD ADAGIO THERAPEUTICS INC 0.9%

Value ($000) $8,834 Shares 1,937,207 Est. Cost $37.11 Unrealized -83.5%

NAUT NAUTILUS BIOTECHNOLOGY INC 0.8%

Value ($000) $8,680 Shares 2,000,000 Est. Cost $10.83 Unrealized -62.1%

— SYROS PHARMACEUTICALS INC 0.7%

Value ($000) $7,455 Shares 6,264,420 Est. Cost $10.27 Unrealized —

— ARYA SCIENCES ACQU CORP IV 0.7%

Value ($000) $6,860 Shares 700,000 Est. Cost $10.47 Unrealized —

— AEGLEA BIOTHERAPEUTICS INC 0.6%

Value ($000) $6,550 Shares 2,847,689 Est. Cost $9.18 Unrealized —

— X4 PHARMACEUTICALS INC 0.5%

Value ($000) $5,284 Shares 3,019,540 Est. Cost $7.84 Unrealized —

— PANACEA ACQUISITION CORP II 0.5%

Value ($000) $4,875 Shares 500,000 Est. Cost $10.02 Unrealized —

— ARYA SCIENCES ACQUISITN CORP 0.5%

Value ($000) $4,855 Shares 500,000 Est. Cost $9.88 Unrealized —

— BCLS ACQUISITION CORP 0.5%

Value ($000) $4,812 Shares 487,500 Est. Cost $11.14 Unrealized —

— OMEGA ALPHA SPAC 0.4%

Value ($000) $3,928 Shares 400,000 Est. Cost $9.90 Unrealized —

— FRAZIER LIFESCIENCES ACQU CO 0.3%

Value ($000) $2,997 Shares 300,000 Est. Cost $10.38 Unrealized —

— JIYA ACQUISITION CORP 0.3%

Value ($000) $2,949 Shares 300,000 Est. Cost $10.30 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	SPRINGWORKS THERAPEUTICS INC	4,831,307	$272,679	26.5%	$21.68	—	COM	85205L107
—	DYNAVAX TECHNOLOGIES CORP	8,415,000	$91,219	8.9%	$9.83	—	COM NEW	268158201
ARQT	ARCUTIS BIOTHERAPEUTICS INC	3,979,292	$76,641	7.4%	$26.87	-37.0%	COM	03969K108
PHVS	PHARVARIS N V	3,180,601	$57,680	5.6%	$31.46	-44.1%	COM	N69605108
RPID	RAPID MICRO BIOSYSTEMS INC	8,434,560	$57,271	5.6%	$20.66	-64.4%	CLASS A COM	75340L104
NUVL	NUVALENT INC	3,428,014	$47,615	4.6%	$29.01	-49.9%	COM	670703107
CRNX	CRINETICS PHARMACEUTICALS IN	2,029,701	$44,552	4.3%	$18.52	+9.3%	COM	22663K107
—	EQRX INC	10,003,573	$41,315	4.0%	$6.82	—	COM	26886C107
CCCC	C4 THERAPEUTICS INC	1,642,210	$39,840	3.9%	$29.00	-16.3%	COM STK	12529R107
AMLX	AMYLYX PHARMACEUTICALS INC	2,756,050	$35,415	3.4%	$22.45	0.0%	COM	03237H101
—	MERSANA THERAPEUTICS INC	6,522,030	$26,023	2.5%	$15.29	—	COM	59045L106
—	2SEVENTY BIO INC	1,408,901	$24,036	2.3%	$18.15	—	COMMON STOCK	901384107
—	APTINYX INC	8,891,758	$20,184	2.0%	$8.16	—	COM	03836N103
XLO	XILIO THERAPEUTICS INC	2,805,413	$19,834	1.9%	$17.03	-33.7%	COM	98422T100
NRIX	NURIX THERAPEUTICS INC	1,284,313	$17,993	1.7%	$25.20	-29.6%	COM	67080M103
AVIR	ATEA PHARMACEUTICALS INC	2,485,638	$17,946	1.7%	$32.23	-78.9%	COM	04683R106
SVRA	SAVARA INC	11,622,598	$15,226	1.5%	$1.49	-19.0%	COM	805111101
TNGX	TANGO THERAPEUTICS INC	1,921,790	$14,567	1.4%	$11.99	-27.7%	COM	87583X109
—	MARINUS PHARMACEUTICALS INC	1,431,058	$13,380	1.3%	$15.48	—	COM NEW	56854Q200
—	RESEARCH ALLIANCE CORP II	1,000,000	$9,760	0.9%	$10.25	—	COM CL A	760873109
—	SOLID BIOSCIENCES INC	7,929,918	$9,516	0.9%	$7.99	—	COM	83422E105
ANNX	ANNEXON INC	3,241,628	$8,850	0.9%	$23.46	-73.8%	COM	03589W102
IVVD	ADAGIO THERAPEUTICS INC	1,937,207	$8,834	0.9%	$37.11	-83.5%	COM	00534A102
NAUT	NAUTILUS BIOTECHNOLOGY INC	2,000,000	$8,680	0.8%	$10.83	-62.1%	COM	63909J108
—	SYROS PHARMACEUTICALS INC	6,264,420	$7,455	0.7%	$10.27	—	COM	87184Q107
—	ARYA SCIENCES ACQU CORP IV	700,000	$6,860	0.7%	$10.47	—	CL A	G31659108
—	AEGLEA BIOTHERAPEUTICS INC	2,847,689	$6,550	0.6%	$9.18	—	COM	00773J103
—	X4 PHARMACEUTICALS INC	3,019,540	$5,284	0.5%	$7.84	—	COM	98420X103
—	PANACEA ACQUISITION CORP II	500,000	$4,875	0.5%	$10.02	—	CL A SHS	G6882C106
—	ARYA SCIENCES ACQUISITN CORP	500,000	$4,855	0.5%	$9.88	—	CLASS A ORD SHS	G31658100
—	BCLS ACQUISITION CORP	487,500	$4,812	0.5%	$11.14	—	COM CL A	G0904B105
—	OMEGA ALPHA SPAC	400,000	$3,928	0.4%	$9.90	—	CL A	G6749V107
—	FRAZIER LIFESCIENCES ACQU CO	300,000	$2,997	0.3%	$10.38	—	UNIT 12/09/2025	G3710A121
—	JIYA ACQUISITION CORP	300,000	$2,949	0.3%	$10.30	—	COM CL A	47760M102